In the first half of 2010, the company posted a net profit of RON1.53 million.
Farmaceutica Remedia said total sales rose 7.5% to RON95.2 million in January to June, from RON88.6 million in the year-earlier period.
The company reported overall revenue of RON96.7 million, up 6.4% on the year, while total costs were up 4.8% to RON93.3 million.
Farmaceutica estimates total revenue of RON224.02 million in 2011, up 21.2% on the year, while overall costs are expected to increase at a similar pace, to RON220.28 million.
Managing board president Valentin Norbert Tarus holds 66.05% of the company’s shares, while Lutz Stache controls a stake of some 16.5%.
On the Bucharest bourse Thursday, Farmaceutica Remedia closed flat at RON0.165 a share. (EUR1=RON4.2855)